Clinical pharmacokinetics of tiaprofenic acid and its enantiomers

Clinical Pharmacokinetics

Volumn 31, Issue 5, 1996, Pages 331-347

  Davies, Neal M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENPROCOUMON; PROBENECID; SULFAMETHIZOLE; TIAPROFENIC ACID;

AGE; AREA UNDER THE CURVE; CARTILAGE; CHEMICAL STRUCTURE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; ENANTIOMER; HUMAN; KIDNEY FUNCTION; MUSCULOSKELETAL DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STEREOCHEMISTRY; SYNOVIAL FLUID; SYNOVIUM;

EID: 0029860284     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199631050-00002     Document Type: Review

References (96)

1. Deraedt R, Benzoni J, Delevallée F. Pharmacological profile of tiaprofenic acid. In: Huskisson R, Katona G, editors. Rheumatology, an annual review, new trends in osteoarthritis. Basel: Karger, 1982: 78-87
2. Camp AV. Tiaprofenic acid in the treatment of rheumatoid arthritis. Rheumatol Rehabil 1981; 20: 181-3
3. Wojtulewski JA, Walter J, Thorton EJ. Tiaprofenic acid (Surgam®) in the treatment of osteoarthritis of the knee and hip. Rheumatol Rehabil 1981; 20: 177-80
4. Scarpa R, Oriente P, Longalti S. Efficacy and tolerability of an injectable formulation of tiaprofenic acid in patients with acute back and neck pain. Drugs 1988; 35 Suppl. 1: 81-9
5. Pini LA, Bertolotti M, Bergnzini G, et al. Pharmacokinetics of tiaprofenic acid after oral administration in fasting patients during and between migraine attacks. Headache 1990; 30: 672-5
6. Vauzelle-Kervroëden F, Reuzani Y, Pons G, et al. Antipyretic-efficacy of tiaprofenic acid in febrile children. Fundam Clin Pharmacol 1996; 10 (1): 56-9
7. Allison N, Shantz I. Delirium related to tiaprofenic acid. Can Med Assoc J 1987; 137: 1022-3
8. Diffy BL, Daymond TJ, Fairgreaves H. Phototoxic reactions to piroxicam, naproxen, and tiaprofenic acid. Br J Rheumatol 1983; 22: 239-42
9. Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin Pharmacokinet 1995; 28 (2): 100-14
10. Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet 1990; 19 (3): 197-217
11. Brocks DR, Jamali F. Etodolac clinical pharmacokinetics. Clin Pharmacokinet 1994; 26 (4): 259-74
12. Brocks DR, Jamali F. Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 1992; 23 (6): 415-27
13. Evans AM. Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 1992; 42: 237-56
14. Singh NN, Jamali F, Pasutto FM, et al. Pharmacokinetics of the enantiomers of tiaprofenic acid in humans. J Pharm Sci 1986; 75: 439-42
15. Vakily M, Jamali F. Human pharmacokinetics of tiaprofenic acid after regular and sustained release formulations: lack of chiral inversion and stereoselective release. J Pharm Sci 1994; 83 (4): 495-98
16. Mehvar R, Jamali F, Pasutto FM. Rapid and sensitive high-performance liquid chromatographic assay of tiaprofenic acid enantiomers in human plasma and urine. J Chromatogr 1988; 425: 1135-42
17. Muller N, Lapicque F, Drelon E, et al. Direct high-performance liquid chromatographic resolution of the enantiomers of tiaprofenic acid immobilized human serum albumin. J Chromatogr 1993; 616: 261-70
18. Vakily M, Jamali F. Pharmacokinetics of tiaprofenic acid in humans: lack of stereoselectivity in plasma using both direct and precolumn derivatization. J Pharm Sci 1996; 85 (6): 638-42
19. Jamali F, Mehvar R, Russell AS. Pharmacokinetics of tiaprofenic acid enantiomers in renal dysfunction. Japan-US Congress on Pharmaceutical Science; 1988 Dec 2-7; Honolulu
20. Lapicque F, Mainard D, Gillet P, et al. Stereoselective distribution of tiaprofenic acid in synovium and cartilage in human. Eur J Clin Pharmacol 1996; 50 (4): 283-7
21. Geisslinger G, Menzel S, Brune K. Stercospecific determination of tiaprofenic acid in plasma: problems with drug degradation. J Chromatogr B Biomed Appl 1996; 675 (1): 77-81
22. Vakily M, Jamali F. Pharmacokinetics of tiaprofenic acid in humans: lack of stereoselectivity regardless of analytical method used for quantification of plasma samples. Pharm Res 1995; 12 (9 Suppl.): S-22
23. Sorkin EM, Brogden RN. Tiaprofenic acid: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs 1985; 29 (3): 208-35
24. Plosker GL, Wagstaff AJ. Tiaprofenic acid: a reappraisal of its pharmacological properties and use in the management of rheumatic diseases. Drugs 1995; 50 (6): 1050-75
25. Mohamed ME, Abdel-Aziz MW, Gad-Kariem ER, et al. Rapid differential pulse polarographic determination of tiaprotenic acid. J Assoc Off Anal Chem 1984; 67 (4): 634-8
26. Pottier J, Berlin D, Raynaud JP. Pharmacokinetics of the antiinflammatory tiaprofenic acid in humans, mice, rats, rabbits, and dogs. J Pharm Sci 1977; 66: 1030-6
27. Singh NN, Pasutto FM, Coutts RT, et al. Gas Chromatographic separation of optically active anti-inflammatory 2-arylpropionic acids using (+) - or (-) - amphetamine as derivatizing reagent. J Chromatogr 1986; 378: 125-35
28. Jamali F, Russell AS, Berry BW, et al. High-performance liquid chromatographic analysis of tiaprofenic acid and its metabolites in plasma and urine by direct injection. J Chromatogr 1984; 310: 327-33
29. Ward GT, Stead JA, Freeman M. A rapid and specific method for the determination of tiaprofenic acid in human plasma by high-performance liquid chromatography. J Liq Chromatogr 1982; 5: 165-74
30. Pirkle WH, Welch CJ. An improved chiral stationary phase for the chromatographic separation of underivatized naproxen enantiomers. J Liq Chromatogr 1992; 15 (11): 1947-55
31. Okamoto Y, Aburatani R, Kaida Y, et al. Direct chromatographic separation of 2-arylpropionic acid enantiomers using tri(3,5-dimethylphenylcarbamate)s of cellulose and amylose as chiral stationary phases. Chirality 1989; 1: 239-42
32. Feretti R, Gallinella B, La Torre F, et al. Direct high-performance liquid chromatography resolution on chiral columns of tiaprofenic acid and related compounds in bulk powder and pharmaceutical formulations. J Chromatogr 1993; 704: 217-23
33. Nilsen OG, Storhaug A, Dale O. Binding of tiaprofenic acid to human sera and isolated serum proteins. Arzneimittel Forschung 1985; 35 (1): 984-7
34. Koppel C, Wagemann A, Tenczer J, et al. Tiaprofenic acid over-dose. Arzneimittel Forschung 1984; 34 (2): 836-7
35. Lücker PW, Penth B, Wetzelsberger K. Pharmacokinetic interaction between tiaprofenic acid and several other compounds for chronic use. In: Huskisson R, Katona G, editors. Rheumatology, an annual review, new trends in osteoarthritis. Basel: Karger, 1982: 99-106
36. Rieck W, Platt D. Determination of 2-(5-benzoyl-2-thienyl)-propionic acid (tiaprofenic acid) in the plasma of elderly patients with multiple diseases using high-performance liquid chromatography. J Chromatogr 1987; 421: 206-10
37. Marecek N, Lücker PW, Penth B, et al. On the pharmacokinetics of tiaprofenic acid and its possible interactions with aluminum hydroxide [in German]. Arzneimittel Forschung 1981; 31: 116-20
38. De Bernardi M, Feletti F, Tripodi AS. Pharmacokinetics and bioequivalence of a drug containing tiaprofenic acid in healthy volunteers. Acta Toxciol Ther 1991; 12(4): 361-78
39. Maboundou CW, Paintaud G, Berard M, et al. Separation of fifteen non-steroidal anti-inflammatory drugs using micellar electrokinetic capillary chromatography. J Chromatogr 1994; 657: 173-83
40. Gasparinni F, Misiti D, Villani C, et al. Direct high-performance liquid chromatographic resolution of 2-aryl- and 2-hetero-arylpropionic acids on a chiral stationary phase containing the N.N′-dinitrobenzoyl derivative of (1 R, 2 R)-diaminocyclohexane. J Chromatogr 1993; 633: 81-7
41. Hutt AJ, Hadley MR, Tan SC. Enantiospecific analysis: applications in bioanalysis and metabolism. Eur J Drug Metab Pharmacokinet 1994; 3: 241-51
42. Hermansson J, Hermansson I. Dynamic modification of the chiral bonding properties of a CHIRAL-AGP column by organic and inorganic additives: separation of enuntiomers of anti-inflammatory drugs. J Chromatogr 1994; 666: 181-91
43. Van Overbeke A, Baeyens W, Van Den Bossche W, et al. Separation of 2-arylpropionic acids on a cellulose based chiral stationary phase by RP-HPLC. J Pharm Biomed Anal 1994; 12: 901-9
44. Van Overbeke A, Baeyens W, Van Den Bossche W, et al. Enantiomeric separation of amide derivatives of some 2-arylpropionic acids by HPLC on a cellulose-based chiral stationary phase. J Pharm Biomed Anal 1994; 12: 911-6
45. Van Overbeke A, Baeyens W, Dewaele C. Enantiomeric separation of six 2-arylpropionic acids after pre-column derivatization with various amines and alchohols on a cellulose-based chiral stationary phase. Anal Chim Acta 1996; 321: 245-61
46. Bechet I, Fillet M, Hubert P, et al. Quantitative analysis of non-steroidal anti-inflammatory drugs by capillary zone electrophoresis. J Chromatogr 1995; 13 (4-5): 497-503
47. Karger AE, Stoll E, Hänsel W. Direct chiral separation of tiaprofen, carproten and flurbiprofen by cyclodextrin-modified capillary electrophoresis [in German]. Pharmazie 1994; 49 (2-3): 155-9
48. Boscà F, Miranda MA, Vargas F. Photochemistry of tiaprofenic acid, a nonsteroidal anti-inflammatory drug with phototoxic side effects. J Pharm Sci 1992; 81 (2): 181-2
49. Figueiredo A, Fontes Ribeiro CA, Goncalo M, et al. Experimental studies on the mechanisms of tiaprofenic acid photosensitization. J Photo Chem Photobiol B 1993; 18 (2-3): 161-8
50. Pottier J, Coutsy-Berlin D, Busigny M. Human pharmacokinetics of tiaprofenic acid. In: Huskisson R, Katona G. editors. Rheumatology, an annual review, new trends in osteoarthritis. Basel: Karger, 1982: 70-7
51. Daymond TJ, Herbert R. Simultaneous bioavailability of tiaprofenic acid (Surgam®) in serum and synovial fluid in patients with rheumatoid arthritis. Rheumatology 1982; 7: 188-93
52. Jamali F, Russell AS, Lehmann C, et al. Pharmacokinetics of tiaprofenic acid in healthy and arthritic subjects. J Pharm Sci 1985; 74 (9): 953-6
53. Nilsen OG, Wessel-Aas T, Walseth F. Single dose pharmacokinetics of tiaprofenic acid: effects of food and severe renal insufficiency. Arzneimittel Forschung 1985; 35 (1): 871-5
54. Nilsen OG, Jacobsen G, Walstead RA. Steady state pharmacokinetics of tiaprofenic acid in elderly patients. Arzneimittel Forschung 1985; 35 (1): 875-9
55. Hosie J, Hosie GAC. The pharmacokinetics of single and multiple doses of tiaprofenic acid in elderly patients with arthritis. Eur J Clin Pharmacol 1987; 32: 93-5
56. Hosie GA, Hosie J. The pharmacokinetics of sustained release tiaprofenic acid in elderly arthritic patients. Br J Clin Pharmacol 1987; 24: 93-5
57. Pini LA, Casalgrandi L, Bertolotti M, et al. Pharmacokinetics of tiaprofenic acid in headache attacks: a preliminary report. Pharmacol Res 1989; 21 (4): 447-9
58. De Ponti F, D'angelo L, Paparella F. Therapeutic efficacy and pharmacokinetics of tiaprofenic acid vs. tiaprofenic acid plus β cyclodextrin. Arch Med Intern 1990; 42 (3-4): 182-7
59. Platt D, Rieck W, Hilgert D, et al. Pharmacokinetics of tiaprofenic acid in geriatric patients with ischemic heart disease. Arch Gerontol Geriatr 1989; 8: 105-15
60. Bertin L, Rey R, Pons G, et al. Pharmacokinetics of tiaprofenic acid in children after a single oral dose. Eur J Clin Pharmacol 1991; 41: 251-3
61. Cerretani D, Fiaschi AI, Michell L, et al. Pharmacokinetic study on tiaprofenic acid in elderly. Arch Gerontol Geriatr 1991; 2: 539-44
62. Daymond TJ, Herbert R. Pharmacokinetic studies of tiaprofenic acid in patients suffering from rheumatic arthritis. Ann Rheum Dis 1981; 40: 622
63. Nilsen OG. The pharmacokinetics of tiaprofenic acid (Surgam®). Eular Symposium on Arthrosis; 1984 Sep 5-9; Regensburg
64. Daymond TJ, Herbert R. Pharmacokinetic studies of a high dose of tiaprofenic acid in patients suffering from arthritis. Br J Clin Pharmacol 1983; 15: 157-8
65. Verbeeck RK. Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs. J Rheumatol 1988; 17 Suppl.: 44-57
66. 2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Drugs 1988; 35 Suppl. 1: 4-8
67. Meirovich CI, Montrull HL, Strusberg AM, et al. Clinical pharmacodynamics of tiaprofenic acid [in Spanish]. Medicina (B Aires) 1986; 46: 59-63
68. 2 activity, prostaglandins, neutral protease, and collagenase activity in rheumatoid synovial fluid. Semin Arthritis Rheum 1989; 17 (3 Suppl. 1): 11-5
69. Kurowski M. Transsynovialkinetik der tiaprofensäure. Z Rheumatol 1988; 47: 173-6
70. Strusberg AM, Arroyo SR, Montrull HL, et al. Tiaprofenic acid pharmacokinetics in rheumatoid arthritis and osteoarthritis. Third International Seminar on the Treatment of Rheumatic Diseases: 1983 Nov 13-20; Jerusalem, Israel, 13-20
71. Nichol FE, Samanta A, Rose CM. Synovial fluid kinetics of repeated dose sustained action tiaprofenic acid in patients with rheumatoid arthritis. Drugs 1988; 35 Suppl. 1: 46-51
72. Mira E, Benazzo M, Galioto P, et al. Tiaprofenic acid: levels in plasma and upper airway tissues. Acta Otorhinolaryngol Ital 1990; 28: 47-52
73. Kaneto H, Matsui Y. Metabolic fate of tiaprofenic acid (RU-1560)(1) absorption, distribution and excretion following oral administration in the rat and dog. Pharmacometrics 1977; 13: 399-409
74. Clemence F, Le Martret O, Fournex R, et al. Recheche de composes anti-inflammatoires et analgesiques dans la serie du thiophene, Eur J Med Chim Ther 1974; 9: 390
75. Essigman W, Lambert J, Sheldon P, et al. A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis, Int J Clin Pharm Res 1987; 4: 251-7
76. Phillips G, Selfridge DI, Haves G, et al. Comparison of sustained-release with standard tiaprofenic acid in the treatment of rheumatic diseases in general practice. Curr Med Res Opin 1987; 10: 486-93
77. Day RO, Furst DE, Dromogoole SH, et al. Relationship between concentration and efficacy in rheumtoid arthritis. Clin Pharmacol Ther 1982; 31 (6): 733-40
78. Furst DE, Caldwell JR, Klugman MP, et al. Serum concentration and dose-response relationships for carprofen in rheumatoid arthritis. Clin Pharmacol Ther 1988; 44: 186-94
79. Laska EM, Sunshine A, Marrero I. The correlation between blood levels of ibuprofen and analgesic response. Clin Pharmacol Ther 1986; 40 (1): 1-7
80. Fibbi G, Serni U, Pucci M, et al. Plasminogen activators and tiaprofenic acid in inflammation: a preliminary study. Drugs 1988; 35 Suppl. 1: 9-14
81. Blackshear JL, Davidman M, Stillman MT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983; 143 (6): 1130-4
82. Ishioka T. Is tiaprofenic acid different from other NSAIDs with regard to effects on renal function in the elderly? Drugs 1988; 35 Suppl. 1: 95-100
83. Upton RA, Buskin JN, Williams RL, et al. Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine. J Pharm Sci 1980; 69 (11): 1254-7
84. Volans GN. Migraine and drug absorption Br J Clin Pharmacol 1975; 2: 57-63
85. Platt D, Eicher H, Rieck W, et al. Pharmacokinetics of tiaprofenic acid in elderly multimorbid patients. Drugs 1988; 35 Suppl. 1: 53-6
86. Baeumont VJ, Scott SM, Greef OBW, et al. Tiaprofenic acid: a South African multicentre open evaluation in musculoskeletal disorders. S Afr Med J 1983; Suppl.: 9-13
87. Sinigaglia L, Zeni S, Solazzi F, et al. The effect of tiaprofenic acid on uric acid excretion in man. Drugs 1988; 35 Suppl. 1: 68-71
88. Coladangelo R. Liver dysfunction caused by tiaprofenic acid [letter]. Lancet 1986; 1 (8484): 803
89. Benarrosh C. Etude multicentrique de l'acide tiaprofénique versus placebo en double insu dans les angines et pharyngites de l'enfant. Arch Fr Pediatr 1989; 46: 541-6
90. Upton RA, Williams RL, Buskin JN, et al. Effects of probenecid on ketoprofen pharmacokinetics. Eur J Clin Pharmacol 1987; 23: 189-93
91. Dürr J, Pfeiffer MH, Penth B, et al. Study on possible interactions between tiaprofenic acid and phenprocoumon [in German]. Arzneimittel Forschung 1981; 31: 2163-7
92. Furst DE. Clinically important interactions of nonsteroidal anti-inflammatory drugs with other medications. J Rheumatol 1988; 17 Suppl.: 58-62
93. Doering VW, Isbary J. Effect of tiaprofenic acid on serum digoxin concentration. Arzneimittel Forschung 1983; 33: 167-8
94. Chiba K, Kikuchi S, Nishimura S, et al. Study of the interactions between sulfamethizole and aclofenac, diclofenac or tiaprofenic acid in rats. Chem Pharm Bull Tokyo 1987; 35 (2): 883-6
95. Meurice J. Interaction of tiaprofenic acid and acenocoumarol. Rheumatology 1982; 7: 111-7
96. Whittakker SJ, Jackson CW, Whorwell PJ. A severe, potentially fatal, interaction between tiaprofenic acid and nicoumalone. Br J Clin Prac 1986; 40 (10): 440